Docoh
Loading...
Sign up Log in

ZYXI Zynex

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex also has a blood volume monitor for use in hospitals and surgery centers.

Company profile

Ticker
ZYXI
Exchange
NASDAQ
Website
www.zynex.com
CEO
Thomas Sandgaard
Employees
Incorporated
Nevada
Location
Colorado
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Electromedical & Electrotherapeutic Apparatus
Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...
Former names
ARIZONA VENTURES INC, CHINA GLOBAL DEVELOPMENT INC, FOX RIVER HOLDINGS INC, IBONZAI COM INC, LIFE MEDICAL TECHNOLOGIES INC /UT/, ZYNEX MEDICAL HOLDINGS INC, ZYNEX MEDICAL HOLDINGS INC
SEC CIK
0000846475
Corporate docs
IRS number
870403828

ZYXI stock data

(
)

News

Pro users get this 30m faster
63 Biggest Movers From Friday
2 Aug 21
Gainers
12 Health Care Stocks Moving In Friday's Intraday Session
30 Jul 21
Gainers
41 Stocks Moving In Friday's Mid-Day Session
30 Jul 21
Gainers
12 Health Care Stocks Moving In Friday's Pre-Market Session
30 Jul 21
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
30 Jul 21

Press releases

Pro users get this 30m faster
Zynex Announces 2021 Second Quarter Earnings
29 Jul 21
ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ -- 2021 Second Quarter Revenue increased 61% year over
Zynex Schedules 2021 Second Quarter Earnings Call
21 Jul 21
ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke
Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate
15 Jul 21
ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke
Zynex Announces Uplisting to the Nasdaq Global Select Market®
13 Jul 21
Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference
8 Jul 21

Calendar

29 Jul 21
2 Aug 21
31 Dec 21

Financial summary

Financial statements Chart ZYXI financial data
Quarter (USD)
 Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Zynex earnings reports.

Recent insider trades

ZYXI insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
29 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 1,642 0 62,343
29 Jul 21 Sandgaard Thomas Common Stock (Restricted Stock Award) Grant Aquire A No No 0 4,106 0 5,860
29 Jul 21 Daniel J Moorhead Common Stock (Restricted Stock Award) Grant Aquire A No No 0 4,106 0 96,393
27 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 5,000 0 60,000
27 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 5,000 0 60,701
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

ZYXI institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

35.0% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 119 125 -4.8%
Opened positions 18 21 -14.3%
Closed positions 24 33 -27.3%
Increased positions 40 41 -2.4%
Reduced positions 42 41 +2.4%
13F shares
 Current Prev Q Change
Total value 241.94M 235.07M +2.9%
Total shares 12.18M 13.44M -9.4%
Total puts 176.4K 436.5K -59.6%
Total calls 250.3K 417.6K -40.1%
Total put/call ratio 0.7 1.0 -32.6%
Largest owners
 Shares Value Change
BLK Blackrock 3.09M $47.17M +6.5%
Sandgaard Thomas 1.3M $17.02M 0.0%
Vanguard 1.24M $18.96M +12.0%
STT State Street 518.4K $7.92M +0.5%
Punch & Associates Investment Management 481.54K $7.35M +11.8%
Geode Capital Management 325.74K $4.97M +9.1%
Millennium Management 299.4K $4.57M +12.2%
NTRS Northern Trust 243.12K $3.71M -2.3%
Susquehanna International 235.82K $3.6M -6.2%
Capital Impact Advisors 226.92K $3.47M -17.6%
Largest transactions
 Shares Bought/sold Change
Hood River Capital Management 0 -1.14M EXIT
Nuveen Asset Management 70.67K -246.65K -77.7%
GS Goldman Sachs 11.72K -242.92K -95.4%
Tygh Capital Management 223.2K +223.2K NEW
BLK Blackrock 3.09M +188.83K +6.5%
Vanguard 1.24M +132.77K +12.0%
Charles Schwab Investment Management 47.11K -112.51K -70.5%
WFC Wells Fargo & Co. 173.04K +109.48K +172.2%
Voloridge Investment Management 0 -83.05K EXIT
Janney Montgomery Scott 72.73K +72.73K NEW
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
Removed: drove, filing
From filing 10-Q 2021 Q2

Financial reports

View all
10-Q
2021 Q2
Quarterly report
29 Jul 21
10-Q
2021 Q1
Quarterly report
29 Apr 21
10-K
2020 FY
Annual report
25 Feb 21
10-Q
2020 Q3
Quarterly report
27 Oct 20
10-Q
2020 Q2
Quarterly report
28 Jul 20
10-Q
2020 Q1
Quarterly report
28 Apr 20
10-K
2019 FY
Annual report
26 Feb 20
10-Q
2019 Q3
Quarterly report
29 Oct 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
10-Q
2019 Q1
Quarterly report
30 Apr 19

Current reports

View all
8-K
Zynex Announces 2021 Second Quarter Earnings
29 Jul 21
8-K
Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate
15 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
25 May 21
8-K
Zynex Announces 2021 First Quarter Earnings
29 Apr 21
8-K
Zynex Announces 140% Year over Year Order Growth in Q1-2021
12 Apr 21
8-K
Entry into a Material Definitive Agreement
9 Apr 21
8-K
Zynex Announces Share Buyback Program
8 Mar 21
8-K
Zynex Announces 2020 Fourth Quarter and Full Year Earnings
25 Feb 21
8-K
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
28 Jan 21
8-K
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate
12 Jan 21

Registration and prospectus

View all
424B5
Prospectus supplement for primary offering
16 Jul 20
424B7
Prospectus with selling stockholder info
16 Jul 20
424B5
Prospectus supplement for primary offering
14 Jul 20
424B7
Prospectus with selling stockholder info
14 Jul 20
424B5
Prospectus supplement for primary offering
29 Oct 19
S-3
Shelf registration
26 Jun 19
S-3
Shelf registration
7 Mar 19
8-A12B
Registration of securities on exchange
7 Feb 19
S-8
Registration of securities for employees
5 Sep 17
D
$1.5M in equity / debt
24 Nov 16

Proxies

DEF 14A
Definitive proxy
2 Apr 21
DEFA14A
Additional proxy soliciting materials
2 Apr 20
DEF 14A
Definitive proxy
2 Apr 20
PRE 14C
Preliminary information
26 Aug 02

Other

View all
EFFECT
Notice of effectiveness
5 Jul 19
UPLOAD
Letter from SEC
1 Jul 19
CORRESP
Correspondence with SEC
30 Jun 19
EFFECT
Notice of effectiveness
13 Mar 19
UPLOAD
Letter from SEC
28 Sep 09
CORRESP
Correspondence with SEC
17 Sep 09
UPLOAD
Letter from SEC
7 Sep 09
CORRESP
Correspondence with SEC
23 Aug 09
UPLOAD
Letter from SEC
14 Jul 09
EFFECT
Notice of effectiveness
11 Sep 08

Ownership

View all
4
ZYNEX / DANIEL J MOORHEAD ownership change
30 Jul 21
4
ZYNEX / Thomas Sandgaard ownership change
30 Jul 21
4
ZYNEX / Anna Lucsok ownership change
30 Jul 21
4/A
ZYNEX / Anna Lucsok ownership change
30 Jul 21
4
ZYNEX / Anna Lucsok ownership change
29 Jul 21
4
ZYNEX / Joshua R. Disbrow ownership change
19 Jul 21
4
ZYNEX / BARRY D MICHAELS ownership change
19 Jul 21
4
ZYNEX / Michael D Cress ownership change
19 Jul 21
4
ZYNEX / DANIEL J MOORHEAD ownership change
9 Jul 21
4
ZYNEX / DANIEL J MOORHEAD ownership change
14 Jun 21

Transcripts

View all
2021 Q2
Earnings call transcript
30 Jul 21
2021 Q1
Earnings call transcript
30 Apr 21
2020 Q4
Earnings call transcript
26 Feb 21
2020 Q3
Earnings call transcript
27 Oct 20
2020 Q2
Earnings call transcript
28 Jul 20
2020 Q1
Earnings call transcript
28 Apr 20
2019 Q4
Earnings call transcript
27 Feb 20
2019 Q3
Earnings call transcript
29 Oct 19
2019 Q2
Earnings call transcript
4 Aug 19
2019 Q1
Earnings call transcript
4 May 19

Reddit threads

Pro users get this 30m faster